Overview

The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This is an open-label, single-arm, multicenter, extension study to evaluate the long-term safety and efficacy of CM310 in patients with CRSwNP.
Phase:
Phase 2
Details
Lead Sponsor:
Keymed Biosciences Co.Ltd